BRCA1 and breast cancer: Advanced (T2–T4) breast cancers were more common in BRCA1-mutated cases, compared with those with pathogenic germline mutations in other genes (P = 0.08) or those with no pathogenic variants detected (P = 0.05) (Fig. 1d), especially among younger patients (Supplementary Fig. 3c).